HARVARD MANAGEMENT CO INC Q3 2020 Filing

Filed November 13, 2020

Portfolio Value

$1.8T

Holdings

24

Report Date

Q3 2020

Filing Type

13F-HR

All Holdings (24 positions)

#StockSharesValue% PortfolioType
1
RPRXROYALTY PHARMA PLC
14,690,780$618.0B33.99%
2
METAFACEBOOK INC
1,087,633$284.9B15.66%
3
GOOGLALPHABET INC
156,543$229.4B12.62%
4
PANWPALO ALTO NETWORKS INC
726,221$177.7B9.77%
5
ICEINTERCONTINENTAL EXCHANGE IN
1,161,137$116.2B6.39%
6
UBERUBER TECHNOLOGIES INC
2,720,937$99.3B5.46%
7
LNWOSCIENTIFIC GAMES CORP
2,678,571$93.5B5.14%
8
NDQINVESCO QQQ TR
113,262$31.5B1.73%
9
RVMDREVOLUTION MEDICINES INC
670,382$23.3B1.28%
10
RLAYRELAY THERAPEUTICS INC
541,124$23.0B1.27%
11
IVVISHARES TR
64,672$21.7B1.20%
12
GQ9SPDR GOLD TR
119,014$21.1B1.16%
13
GBIOGBXGENERATION BIO CO
506,273$15.6B0.86%
14
PLRXPLIANT THERAPEUTICS INC
562,379$12.7B0.70%
15
NUCANA PLC
2,319,780$12.1B0.66%
16
NRIXNURIX THERAPEUTICS INC
314,762$11.0B0.60%
17
VEAVANGUARD TAX-MANAGED INTL FD
174,041$7.1B0.39%
18
IJRISHARES TR
49,710$3.5B0.19%
19
VWOVANGUARD INTL EQUITY INDEX F
80,360$3.5B0.19%
20
IJHISHARES TR
18,544$3.4B0.19%
21
FULCFULCRUM THERAPEUTICS INC
410,714$3.3B0.18%
22
MAGENTA THERAPEUTICS INC
332,610$2.3B0.12%
23
ASANASANA INC
75,946$2.2B0.12%
24
DYNDYNE THERAPEUTICS INC
107,252$2.2B0.12%